Equity99
Открыть в Telegram
Creating wealth through unfolded research. SEBI Registered Investment Adviser Reg No - INA000005358 Disclaimer: Channel view is purely for educational purposes. Visit our website https://Equity99.com
Больше2025 год в цифрах
120 515
Подписчики
-5724 часа
-3007 дней
-1 22830 день
Архив постов
Фото недоступноПоказать в Telegram
Trend reversal move on daily chart of UNIVASTU
Look at the DAILY chart of UNIVASTU. After down trend stock has formed a trend reversal move on daily chart. MACD also turns bullish. Now above 71 expect rally up to 85/93 levels fast.
Cheapest Infra Stock ( Biggest Movement Expected )
Univastu india 67 / 70
Test Resistance 120 / 140 Sl 58
Coming Days View Strong View
Morning Alert..
*India's core sector momentum stalled as output hits 14-month low in October*
Output from India’s eight core sectors flatlined in October from an upgraded 3.3 per cent uptick in September, as growth in construction-linked sectors and refinery products was negated by marked contractions in energy sectors like coal, natural gas and electricity, according to data released by the Ministry of Commerce and Industry on Thursday. The Index of Core Industries (ICI) stood at 162.4 in October, unchanged from a year ago, and this zero per cent growth represents the worst performance in 14 months. In October 2024, core sectors’ output had registered a growth of 3.8 per cent. The last time the ICI growth was lower than October was in August 2024, when output contracted 1.5 per cent. On a sequential basis, however, October’s core sector output was 1.18 per cent over September levels, when the ICI stood at 160.5, the weakest reading in ten months. Interestingly, six of eight core sectors reported sequential growth, while steel and electricity output shrank 1.68 per cent and 9.93 per cent from their September levels, respectively. Output in coal, which carries the largest weight among the energy components of the ICI, fell 8.5 per cent in October, while crude oil production declined 1.2 per cent, marking the second straight month of contraction and the ninth such occasion in 2025. Electricity generation tanked 7.6 per cent in October, breaking a three-month growth streak, while natural gas output fell 5 per cent for the 16th consecutive month.
*Global market action*
Dow Jones – Up by 0.51% or 234.86 points
FTSE – Up by 0.21% or 20.24 points
CAC – Up by 0.34% or 27.30 points
DAX – Up by 0.50% or 115.93 points
Gift Nifty – Down by 0.05% or 13.50 points
*FII/DII activities*
FII – Bought 283.65Cr worth of shares
DII – Bought 824.46Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.8x
Nifty Bank – 16.6x
*Stocks with high delivery percentage*
Indiamart Intermesh Ltd – 90.7%
Mankind Pharma Ltd – 90.2%
Emami Ltd – 84.2%
The Ramco Cement Ltd – 82.3%
Metropolis Healthcare Ltd – 81.6%
*Primary market activities*
IPO opening today
Sudeep Pharma Ltd (Main board) – Issue size 895Cr
Listing today
Capillary Technologies India Ltd (Main board) – Subscribed 52.98x
*Commodities updates*
Gold – Rs 122751/10gm, Silver – Rs 154080/kg, Brcrude – Rs 5255/barrel, Copper – Rs 996.85/kg.
Hindustan Construction Company (HCC), founded in 1926 by Seth Walchand Hirachand, is a leading Indian infrastructure and engineering firm known for landmark projects such as the Bandra-Worli Sea Link and the Sardar Sarovar Dam. It has played a major role in India's infrastructure development with expertise in hydropower, roads, bridges, tunnels, and urban infrastructure. HCC combines nearly a century of experience with advanced technology and a focus on sustainable construction to maintain industry leadership. Its projects have been pivotal in shaping India’s infrastructure landscape.
Key invest.ent thesis
Robust Order Book and Business Wins - HCC maintains a strong order book, recently standing at about ₹13,152 crore, with new contracts worth ₹2,770 crore, including prestigious projects for Patna Metro and Hindalco Smelter. This strong project pipeline and fresh order inflows reinforce its leadership position in the infrastructure sector, supporting future revenue stability and growth.
Focused Deleveraging and Fundraising - The company has actively reduced its debt levels, repaying ₹339 crore in prepayments during FY26 and planning an additional ₹450 crore repayment soon. It also completed significant fundraises—₹350 crore via a rights issue and ₹600 crore through a Qualified Institutional Placement (QIP)—which has bolstered its working capital and improved liquidity for ambitious execution.
Consistent EBITDA Margin Performance - Despite year-on-year declines in turnover and net profit, HCC has sustained healthy EBITDA margins, reporting 16.1% in Q2 FY26, which underscores operational efficiency and prudent cost management. This focus on profitability and execution keeps the company competitive, even during challenging times.
Successful Project Execution and Strategic Focus - HCC successfully inaugurated key infrastructure assets like Mumbai Metro Line 3 and the Tehri Pumped Storage Project, demonstrating its project management excellence and engineering capabilities. The company’s strategic emphasis on hydro, transport, and water infrastructure projects further positions it to benefit from national growth priorities, expanding its market reach and sectoral strengths.
Special Situation Stock ( High Conviction)
HCC ( HINDUSTAN CONSTRUCTION) CMP 24
TEST RESISTANCE 28 / 30 / 35 SL 21
COMING DAYS VIEW SHORT TERM VIEW
Morning Alert..
*India may raise Saudi oil purchases after pulling away from Russian crude*
India oil imports, Saudi Aramco supply, Russian crude decline, Asia oil demand, OPEC supply increase, India energy shortfall, China Saudi oil cuts, refinery maintenance China, Indian refiners Russian oil, global crude markets. India will be among Asian buyers taking more oil from Saudi Aramco next month after pulling away from Russian crude, though the modest rise has left traders wondering how the world’s third-largest importer will fill a shortfall of up to 1.2 million barrels a day. China, meanwhile, has surprised traders by reducing Saudi imports, a drop some attributed to planned refinery maintenance at a state-owned company and more purchases from other regions such as the Americas. At least 18 to 20 million more barrels were sought by customers across India, Japan, South Korea and Taiwan for December compared with this month, as Saudi’s selling prices were deemed attractive, according to people familiar with the sale, who asked not to be named as they’re not authorized to speak publicly. Sales to China dipped by close to four million barrels. India’s purchases rose about five million barrels month-on-month, they added. The requests were met by Aramco. Still, the amount is only a fraction of what the country needs to fill the gap left by Russian oil after US pressure and sanctions — five out of seven refiners have said they would steer clear of Moscow’s crude.
*Global market action*
Dow Jones – Up by 0.53% or 243.41 points
FTSE – Down by 0.47% or 44.89 points
CAC – Down by 0.18% or 14.16 points
DAX – Down by 0.08% or 17.61 points
Gift Nifty – Up by 0.34% or 89.50 points
*FII/DII activities*
FII – Bought 1580.72Cr worth of shares
DII – Bought 1360.27Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.4x
Nifty Bank – 16.5x
*Stocks with high delivery percentage*
Gland Pharma Ltd – 92.8%
Gujarat State Petronet Ltd – 86.9%
Concord Biotech Ltd – 86.7%
Vijaya Diagnostic Center Ltd – 84.5%
AIA Engineering Ltd – 82.1%
*Commodities updates*
Gold – Rs 123042/10gm, Silver – Rs 154850/kg, Brcrude – Rs 5253/barrel, Copper – Rs 1001.85/kg.
Morning Alert..
*Fresh high: IPO secondary sales rocket towards ₹1 trillion this year*
Funds raised through the offer-for-sale (OFS) component of initial public offerings (IPOs) this calendar year have already surged to a new high of nearly ₹96,000 crore, overtaking last year’s record of ₹95,285 crore. This comes even as total IPO proceeds, at around ₹1.53 trillion so far in 2025, remain ₹7,160 crore shy of the all-time peak of ₹1.59 trillion set the previous year. Fresh capital raised via new share issuance stands at ₹56,796 crore this year, a figure that experts still describe as robust on a standalone basis. With six weeks remaining in this calendar year, the overall IPO tally is on track to eclipse last year’s record. OFS collections also appear set to breach the ₹1 trillion mark for the first time in a single year. Since 2015, nearly three-fourths of total IPO fundraising has been in the form of OFS (₹ 4.73 trillion), while just ₹2.44 trillion has come from primary issuance, according to PRIME Database. Fresh capital from IPOs is typically channelled into capex and often viewed as a barometer of economic activity. OFS, by contrast, signals a shift in ownership, usually involving private equity (PE) investors or promoters trimming stakes.
*Global market action*
Dow Jones – Up by 0.08% or 38.22 points
FTSE – Down by 1.29% or 123.13 points
CAC – Down by 1.90% or 151.09 points
DAX – Down by 1.77% or 409.99 points
Gift Nifty – Up by 0.14% or 35.00 points
*FII/DII activities*
FII – Sold 728.82Cr worth of shares
DII – Bought 6156.83Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.3x
Nifty Bank – 16.5x
*Stocks with high delivery percentage*
Akzo Noble India Ltd – 94.5%
Indiamart Intermesh Ltd – 90.3%
The Ramco Cements Ltd – 83.8%
Motilal Oswal Financial Services Ltd – 82.3%
Timken India Ltd – 81.3%
*Primary market activities*
IPOs opening today
Excelsoft Technologies Ltd (Main board) – Issue size 500Cr
Gallard Steel Ltd (BSE SME) - Issue size 37.50Cr
Listing today
Tenneco Clean Air India Ltd (Main board) – Subscribed 61.79x
*Commodities updates*
Gold – Rs 122701/10gm, Silver – Rs 154627/kg, Brcrude – Rs 5355/barrel, Copper – Rs 995.50/kg.
Morning Alert..
*200% spike in gold import drives India's trade deficit to $41.68 billion*
India’s merchandise trade deficit widened to a record $41.68 billion in October, as gold imports trebled and outbound shipments registered their sharpest contraction in 14 months, according to data released by the commerce department. Merchandise exports fell 11.8 per cent to $34.38 billion, an 11-month low, while goods imports grew 16.66 per cent to an all-time high of $76.06 billion. Exports to the US fell 8.6 per cent to $6.3 billion in October, following the imposition of relatively high 50 per cent tariff on several Indian products. Exports to other key trade partners — the United Arab Emirates (-10.2 per cent), the Netherlands (-22.75 per cent) and the United Kingdom (-27.16 per cent) — also contracted. The merchandise trade deficit had stood at $26.22 billion in October last year, and at 13-month high of $32.15 billion in September this year. Gold imports surged 199.2 per cent year-on-year to $14.72 billion in October, fuelled by pent-up demand and the festival season. Silver imports rose sixfold to $2.72 billion, driven by increased shipments of plain silver from a free-trade agreement partner country, government officials said.
*Global market action*
Dow Jones – Up by 0.21% or 98.02 points
FTSE – Down by 0.24% or 22.94 points
CAC – Down by 0.63% or 51.07 points
DAX – Down by 1.21% or 286.03 points
Gift Nifty – Down by 0.10% or 25.50 points
*FII/DII activities*
FII – Bought 442.17Cr worth of shares
DII – Bought 1465.86Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.5x
Nifty Bank – 16.5x
*Stocks with high delivery percentage*
Atul Ltd – 91%
Sheela Foam Ltd – 86.9%
L&T Technology services Ltd – 80.1%
Emami Ltd – 78.8%
EIH Ltd – 76.8%
*Primary market activities*
Listing today
Mahamaya Lifesciences Ltd (BSE SME) – Subscribed 1.63x
Physics Wallah Ltd (Main board) – Subscribed 1.92x
Workmates Core2Cloud Solution Ltd (BSE SME) – Subscribed 141.38x
Emmvee Photovoltaic Power Ltd (Main board) – Under subscribed
*Commodities updates*
Gold – Rs 122891/10gm, Silver – Rs 155178/kg, Brcrude – Rs 5319/barrel, Copper – Rs 1002.85/kg.
Morning Alert..
*India and China begin discussions for a reverse-trade model for drugs*
India has begun talks with China on a reverse-trade model under which bulk drugs imported from China would be converted into finished dosage forms (FDFs) and exported back. This is a move industry experts believe could unlock about $6 billion in drug product exports against China’s $4 billion bulk drug supplies to India, the Pharmaceutical Exports Promotion Council (Pharmexcil) said. China’s tightly-regulated drug market is slowly opening up to Indian pharmaceutical firms with drug approvals and tender orders under its volume-based procurement (VBP). This comes at a critical time when tariff uncertainty pushes India to look beyond the United States (US). The important shift in strategy is, however, for exploring opportunities for collaboration rather than competition. China is more focused on key starting materials (KSMs), intermediates, and drug substances, whereas India's core strength lies in FDFs. “India began discussions with China on a reverse-trade model, where whatever bulk drugs we import, we propose to trade back through FDF partnerships. We would add value to the drug substance and export it back to China,” Namit Joshi, chairman, Pharmexcil said. He claimed that the potential identified for such arrangements stands at approximately $6 billion worth of drug products, which China could import against its $4 billion export of drug substances to India.
*Global market action*
Dow Jones – Up by 0.00% or 1.62 points
FTSE – Down by 1.13% or 109.31 points
CAC – Down by 0.76% or 62.40 points
DAX – Down by 0.69% or 165.07 points
Gift Nifty – Up by 0.16% or 41.50 points
*FII/DII activities*
FII – Sold 4968.22Cr worth of shares
DII – Bought 8461.47Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.5x
Nifty Bank – 16.4x
*Stocks with high delivery percentage*
Cera Sanitaryware Ltd – 90.7%
ITC Ltd – 87.7%
Brigade Enterprises Ltd – 85.4%
P&G Hygiene & Healthcare care Ltd – 83.7%
UTI AMC Ltd – 83.4%
*Commodities updates*
Gold – Rs 123434/10gm, Silver – Rs 156015/kg, Brcrude – Rs 5340/barrel, Copper – Rs 1007.80/kg.
